BayWa’s Long Slide Continues as Restructuring Milestones Keep Shifting

BayWa's stock hits €10.35, down 50% in a year, as failed renewables sale and debt crisis force a drastic downsizing of the German agri group.

At €10.35, BayWa’s share price has become a running tally of investor disillusionment. The stock slipped another 0.96 percent at Friday’s close, but the daily move is almost beside the point. Over the past twelve months, the shares have lost more than half their value — down 50.48 percent since July 2025 — and now trade 56.69 percent below the 52-week high of €23.90 reached as recently as early December.

That gap between the December peak and today’s level tells the real story. This isn’t a short-term wobble. It’s a structural repricing as the Munich-based agriculture and building materials group tries — and so far fails — to convince the market that its turnaround plan is credible.

The renewables sale that wasn’t

The original rescue blueprint, unveiled last year, relied heavily on one big transaction: the sale of a 51 percent stake in BayWa r.e., the group’s solar and wind project development arm. That deal was supposed to generate €1.7 billion by 2028, money earmarked for a massive debt reduction. But the renewables market has soured, and BayWa has now admitted that the €1.7 billion target is no longer realistic. Without that anchor, the entire restructuring framework looks shaky.

A revised agreement reached with creditors and major shareholders at the end of June bought some time. It extends the restructuring timeline and aims to shore up equity. But the deal is more of a stopgap than a solution. The two largest shareholders, who together control roughly 67.1 percent of BayWa’s stock, have transferred their shares to a trustee as security for the financing partners. Those shares will only be returned if the shareholders inject at least €220 million in a capital increase planned for 2029. If they don’t, the trustee can sell the shares. For minority investors, that arrangement does nothing to resolve the uncertainty — it merely postpones it.

A decade of expansion, unwound

The current crisis has its roots in a two-decade growth spree. Between 2008 and 2023, BayWa’s former CEO pursued an aggressive expansion strategy, building the renewables business, buying Dutch agricultural trading group Cefetra, and acquiring New Zealand apple orchard operator Turners & Growers. What was once marketed as strategic diversification now looks like a credit bubble that has burst.

The restructuring is effectively dismantling that legacy. When the process is complete, BayWa is expected to be a much smaller company, focused almost entirely on its home German agricultural market. That downsizing comes at a direct cost to shareholders. Since the start of the year, the stock has lost 38.39 percent.

Competitors move in while BayWa looks inward

The internal chaos has not gone unnoticed by rivals. Agravis, a competitor, has been pushing into BayWa’s traditional regions, exploiting the vacuum created by the group’s self-absorption. Restructuring pauses are expensive — while BayWa is busy remaking itself, others are taking market share.

Adding to the pressure is a legal investigation. Munich prosecutors are looking into allegations that former board members may have manipulated the group’s 2023 balance sheet, with possible charges of breach of trust. Until those probes are resolved, they hang over every piece of positive operational news.

Technicals confirm the anxiety

The chart tells a grim story. The stock is trading roughly 30 percent below its 200-day moving average, firmly in bear territory. More telling is the annualized 30-day volatility of 70.82 percent — a figure that makes BayWa unsuitable for any conservative portfolio. The relative strength index at 41.8 suggests the stock is no longer technically oversold, but with that kind of volatility, any move — up or down — carries extreme risk.

The restructuring agreement is not expected to become legally binding until autumn 2026. The critical capital increase is scheduled for 2029. In the meantime, the stock’s fate depends on a fragile web of standstill agreements, trustee arrangements, and the uncertain value of BayWa r.e. — a value the group itself has already been forced to write down.

As one manager overseeing the BayWa r.e. restructuring recently put it: “The restructuring is on track, but there is still a long way to go.” He added that further measures would be needed given the deteriorating market conditions.

For now, BayWa’s shares look set to remain a vehicle for short-term traders rather than a home for long-term investors. A sustainable bottom is hard to see when every milestone keeps moving further into the future.